FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309556687> ?p ?o ?g. }

• W4309556687 endingPage "174" @default.
• W4309556687 startingPage "166" @default.
• W4309556687 abstract "Acne vulgaris is the eighth most common disease worldwide and presents with inflammatory and noninflammatory skin lesions along with other dermal abnormalities. Oral spironolactone is used for treating acne vulgaris due to its antiandrogenic properties and inhibition of sebogenesis. Recent evidence shows that spironolactone in topical form has similar efficacy to its oral form with comparatively fewer adverse events associated with its use. However, to establish an evidence-based understanding, this systematic review aims to investigate the efficacy and safety of topical spironolactone in the treatment of acne vulgaris. PubMed, ClinicalTrials.gov, Cochrane library, and Google Scholar were comprehensively searched from the date of inception till March 18, 2022 All the clinical trials experimenting with the role of topical spironolactone in the treatment of acne were included. Articles examining the effects of oral spironolactone or other topical agents were excluded. The Cochrane risk of bias assessment tool (RoB 2.0, version 2019) was used to assess the risk of bias in each study. The study findings have been reported in line with PRISMA 2020 guidelines. The literature search yielded 600 articles. Five clinical trials with 195 patients were included in this review. Out of the five trials, two showed a high risk of bias while three had overall some concerns. Patients treated with topical spironolactone showed a significant decrease in the number of papules (p = 0.004), closed comedones (p < 0.05), and lesions (p < 0.05). Compared to placebo, treatment with 5% spironolactone showed a significant decrease in total lesion count (p = 0.007). In addition, 2% spironolactone showed efficacy over clindamycin and reduced the number of comedones (p < 0.0001), papules (p < 0.0001), and pustules (p < 0.0001) while the acne severity index was also considerably lowered (p < 0.0001). Spironolactone was not found to affect significant skin hydration, sebum, elasticity, melanin, and redness (p > 0.05). Topical spironolactone yields better results than other first-line treatments for acne and displays fewer side effects. However, further large-scale clinical trials are required before spironolactone can be used as the preferred treatment in the clinical management of acne." @default.
• W4309556687 created "2022-11-28" @default.
• W4309556687 creator A5014253282 @default.
• W4309556687 creator A5033807241 @default.
• W4309556687 creator A5034463122 @default.
• W4309556687 creator A5054504475 @default.
• W4309556687 creator A5072739079 @default.
• W4309556687 creator A5073153409 @default.
• W4309556687 creator A5076352952 @default.
• W4309556687 creator A5089140358 @default.
• W4309556687 creator A5091737506 @default.
• W4309556687 date "2022-11-22" @default.
• W4309556687 modified "2023-10-01" @default.
• W4309556687 title "Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials—Does this therapy open a path towards favorable outcomes?" @default.
• W4309556687 cites W1971220253 @default.
• W4309556687 cites W2049940696 @default.
• W4309556687 cites W2067243972 @default.
• W4309556687 cites W2069090091 @default.
• W4309556687 cites W2096780638 @default.
• W4309556687 cites W2109597834 @default.
• W4309556687 cites W2276726626 @default.
• W4309556687 cites W2399714615 @default.
• W4309556687 cites W2585329337 @default.
• W4309556687 cites W2592493816 @default.
• W4309556687 cites W2888764599 @default.
• W4309556687 cites W2895668624 @default.
• W4309556687 cites W3022611548 @default.
• W4309556687 cites W3028369708 @default.
• W4309556687 cites W3081336389 @default.
• W4309556687 cites W3179451806 @default.
• W4309556687 cites W4241964216 @default.
• W4309556687 doi "https://doi.org/10.1111/1346-8138.16637" @default.
• W4309556687 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36412248" @default.
• W4309556687 hasPublicationYear "2022" @default.
• W4309556687 type Work @default.
• W4309556687 citedByCount "1" @default.
• W4309556687 countsByYear W43095566872023 @default.
• W4309556687 crossrefType "journal-article" @default.
• W4309556687 hasAuthorship W4309556687A5014253282 @default.
• W4309556687 hasAuthorship W4309556687A5033807241 @default.
• W4309556687 hasAuthorship W4309556687A5034463122 @default.
• W4309556687 hasAuthorship W4309556687A5054504475 @default.
• W4309556687 hasAuthorship W4309556687A5072739079 @default.
• W4309556687 hasAuthorship W4309556687A5073153409 @default.
• W4309556687 hasAuthorship W4309556687A5076352952 @default.
• W4309556687 hasAuthorship W4309556687A5089140358 @default.
• W4309556687 hasAuthorship W4309556687A5091737506 @default.
• W4309556687 hasConcept C126322002 @default.
• W4309556687 hasConcept C142724271 @default.
• W4309556687 hasConcept C16005928 @default.
• W4309556687 hasConcept C168563851 @default.
• W4309556687 hasConcept C197934379 @default.
• W4309556687 hasConcept C204787440 @default.
• W4309556687 hasConcept C27081682 @default.
• W4309556687 hasConcept C2776379505 @default.
• W4309556687 hasConcept C2776478404 @default.
• W4309556687 hasConcept C2777673923 @default.
• W4309556687 hasConcept C2778198053 @default.
• W4309556687 hasConcept C535046627 @default.
• W4309556687 hasConcept C71924100 @default.
• W4309556687 hasConceptScore W4309556687C126322002 @default.
• W4309556687 hasConceptScore W4309556687C142724271 @default.
• W4309556687 hasConceptScore W4309556687C16005928 @default.
• W4309556687 hasConceptScore W4309556687C168563851 @default.
• W4309556687 hasConceptScore W4309556687C197934379 @default.
• W4309556687 hasConceptScore W4309556687C204787440 @default.
• W4309556687 hasConceptScore W4309556687C27081682 @default.
• W4309556687 hasConceptScore W4309556687C2776379505 @default.
• W4309556687 hasConceptScore W4309556687C2776478404 @default.
• W4309556687 hasConceptScore W4309556687C2777673923 @default.
• W4309556687 hasConceptScore W4309556687C2778198053 @default.
• W4309556687 hasConceptScore W4309556687C535046627 @default.
• W4309556687 hasConceptScore W4309556687C71924100 @default.
• W4309556687 hasIssue "2" @default.
• W4309556687 hasLocation W43095566871 @default.
• W4309556687 hasLocation W43095566872 @default.
• W4309556687 hasOpenAccess W4309556687 @default.
• W4309556687 hasPrimaryLocation W43095566871 @default.
• W4309556687 hasRelatedWork W1978208283 @default.
• W4309556687 hasRelatedWork W1994508586 @default.
• W4309556687 hasRelatedWork W2064879719 @default.
• W4309556687 hasRelatedWork W2085830368 @default.
• W4309556687 hasRelatedWork W2107187998 @default.
• W4309556687 hasRelatedWork W2156485132 @default.
• W4309556687 hasRelatedWork W2955693358 @default.
• W4309556687 hasRelatedWork W3081336389 @default.
• W4309556687 hasRelatedWork W3087174900 @default.
• W4309556687 hasRelatedWork W4200355689 @default.
• W4309556687 hasVolume "50" @default.
• W4309556687 isParatext "false" @default.
• W4309556687 isRetracted "false" @default.
• W4309556687 workType "article" @default.